Treating sleep disorders using desloratadine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31435

Patent

active

061143464

ABSTRACT:
Methods of treating and/or preventing sleep disorders in a human afflicted with upper airway passage allergic inflammation and/or congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis by administering a therapeutically effective amount of desloratadine, alone or in combination with other active agents such as a decongestant as pseudoephedrine are disclosed.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3940485 (1976-02-01), Levinson et al.
patent: 4008796 (1977-02-01), Aylon
patent: 4282233 (1981-08-01), Vilani
patent: 4371516 (1983-02-01), Gregory et al.
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4659716 (1987-04-01), Villani et al.
patent: 4731447 (1988-03-01), Schumacher et al.
patent: 4777170 (1988-10-01), Heinrich
patent: 4783465 (1988-11-01), Sunshine et al.
patent: 4804666 (1989-02-01), Piwinski et al.
patent: 4863931 (1989-09-01), Schumacher et al.
patent: 4990535 (1991-02-01), Cho et al.
patent: 5019591 (1991-05-01), Gardner et al.
patent: 5089496 (1992-02-01), Piwinski et al.
patent: 5100675 (1992-03-01), Cho et al.
patent: 5314697 (1994-05-01), Kwan et al.
patent: 5595997 (1997-01-01), Abert et al.
patent: 5731319 (1998-03-01), Aberg et al.
patent: 5900421 (1999-05-01), Handley et al.
patent: 5939426 (1999-08-01), McCullough
Hartauer, et al., "A Comparison of diffuse reflectance FT-IR spectroscopy and DSC in the characterization of a drug-excipient interaction", Drug Development and Industrial Pharmacy, 1991, 17(4):617-630.
Blaug, et al., "Interaction of dextroamphetamine sulfate with stpay-dried lactose", J. of Pharm. Sciences, 1972, 61(11):1770-1775.
Castello, et al., "Discoloration of tablets containing amines and lactose", J. of Pharm. Sciences, 1962, 51(2):106-108.
Wade, et al., Handbook of Pharmaceutical Excipients (2.sup.nd edition), American Pharma. Assoc. & the Pharma. Press, Royal Pharma. Society of G. Britain, pp. 257-259 (1994).
Wirth, et al., "Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine", J. of Pharm. Sciences, 1998, 87(1):31-39.
Babe, et al., The Pharmacological Basis of Therapeutics (9.sup.th edition), The McGraw-Hill Co. Inc., pp. 581-599 (1996).
Andersen, et al., "Adverse drug interactions clinically important for the dermatologist", Arch Dermatol, 1995, 131:468-473.
Barnett, et al., New Perspectives in Histamine Research, Birkhauser Verlag Basel, pp. 181-196 (1991).
Berge, et al., "Pharmaceutical salts", J. of Pharm. Sciences, 1977, 66(1):1-19.
Berthon, et al., "In Vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3)", Biochem. Pharm., 1994 47(5):789-794.
Brandes, et al., "Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates", J. of the National Cancer Inst., 1994, 86(10):770-775.
Brandes, et al., "Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses", Cancer Research, 1992, 52:3796-3800.
Brion, et al., "Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers", Br. J. clin. Pharmac. 1988, 25:27-32.
Carmeliet, "Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide", The J. of Pharm. And Experimental Therapeutics, 1992, 262(2):809-817.
Cheung, et al., "Investigation of anti-motion sickness drugs in the squirrel monkey", J. Clin. Pharmacol, 1992, 32:163-175.
Clissold, et al., "Loratadine a preliminary review of its pharmacodynamic properties and therapeutic efficacy", Drugs, 1989, 37:42-57.
Cooke, "Glycopyrrolate in bladder dysfunction", SA Medical Journal, 1983, 3.
Craft, "Torsade de pointes after astemizole overdose", Br. Medical Journal, 1986, 292-660.
Dorje, et al., "Antagonist binding profiles of five cloned human muscarinic receptor subtypes", The J. of Pharm. And Experimental Therapeutics, 1991, 256:727-733.
Lunde, Side Effects of Drugs Annual 12; A worldwide yearly survey of new data and trends, Elsevier Science Publishers B.V., 1988, 142-143.
Ebert, "Soft elastic gelatin capsules: a unique dosage form", Pharmaceutical Technology, 1977, 44-50.
Gengo, "Dilemma: Antihistamine selection: Use vs. Side effects", U.S. Pharmacist, Nov. 1990, 59-92.
Regula Herzog, et al., Annual Review of Gerontology and Geriatrics, 1989, 9:74-119.
Hilbert, et al., "Pharmacokinetics and dose proportionality of loratadine", J. Clin. Pharmacol. 1987, 27:694-698.
Housley, et al., "Histamine and related substances influence neurotransmission in the semicircular canal", Hearing Research, 1988, 35:87-98.
Jankowski, et al., "Effect of terfenadine on nasel provocation", Int. Arch. Allergy Immunol., 1993, 101:311-317.
Kaliner, "Nonsedating antihistamines: Pharmacology, clinical efficacy and adverse effects", American Family Physician, Mar. 1992, 45(3):1337-1342.
Kleine-Tebbe, et al., "Inhibition of IgE- and non IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine", J. Allergy Clin. Immunol., 1994, 93:494-500.
Knowles, "Astemizole and terfenadine-induced cardiovascular effects", The Canadian J. of Hospital Pharmacy, Feb. 1992, 45(1):33-37.
Kohl, et al., "Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man", Aviation, Space, and Environmental Medicine, Dec. 1987, 1171-1174.
Kohl, et al., "New pharmacologic approaches to the prevention of space/motion sickness", J. Clin. Pharmacol., 1991, 31:934-946.
Kohl, et al., "Control of nausea and autonomic dysfunction with terfenadine, a peripherally acting antihistamine", Aviation, Space, and Environmental Medicine, May 1991, 392-396.
Kubo, et al., "Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor-binding assay", Japan J. Pharmacol., 1987, 43:277-282.
Lathers, et al., "Pharmacology in space: Part 2. Controlling motion sickness", TiPS, Jun. 1989, 10:243-250.
Levin, et al., "Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder", The J. of Urology, Aug. 1982, 128:396-398.
Lunde, Side Effects of Drugs Annual 14, Elsevier Science Publishers B.V., 1990, 135-143.
Massad, et al., "The pharmacokinetics of intravesical and oral oxybutynin chloride", The J. of Urology, Aug. 1992, 148:595-597.
Miadonna, et al., "Inhibitory effect of H1 antagonist loratadine on histamine release from human basophils", Int. Arch Allergy Immunol., 1994, 105:12-17.
Mirakhur, et al., "Glycopyrrolate: pharmacology and clinical use", Anaesthesia, 1983, 38:1195-1204.
Mitchelson, "Pharmacological agents affecting emesis: A review (Part II)", Drugs, 1992, 43(4):443-463.
Muskat, et al., "The use of scopolamine in the treatment of detrusor instability", The J. of Urology, 1996, 156:1989-1990.
Nelemans, Side Effects of Drug Annual 12, Elsevier Science Publishers B.V., 1988, 144-147.
Parkinson, et al., "Evaluation of Loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice", Biochemical Pharmacology, 1992, 43(10):2169-2180.
Peggs, et al., "Antihistamines: The old and the new", American Family Physician, Aug. 1995,52(2):593-600.
Petrin, "Bewegungskrankheit und ihre therapie/ Eine Ubersicht (Motion sickness and its treatment)", Schweiz, Rundschau Med., 1974, (Praxis) 63:79-81.
Quercia, et al., "Focus on Loratadine: A new second-generation nonsedating H1-receptor antagonist", Hosp. Formul., 1993, 28:137-153.
Resnick, "Urinary incontinence", The Lancet, 1995, 346:94-99.
Roman, et al., "Loratadine--A review of recent finding in pharmacology phamacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine", Clin. Reviews in Allergy, 1993, 11:89-110.
Simons, "H1-receptor antagonists Comparat

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treating sleep disorders using desloratadine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating sleep disorders using desloratadine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating sleep disorders using desloratadine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2212435

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.